Clinical research data services for pharmaceutical trials and regulatory submissions
MMS is a data-focused CRO serving pharma and biotech with clinical trial programming, biostatistics, and regulatory submission support. The tech stack is enterprise-standard (SAS, Veeva RIM, SharePoint, GraphPad Prism) — typical for regulated clinical work — but hiring momentum is concentrated in data (23 open roles) and operations (23), not research or programming, suggesting internal focus on automation, proposal efficiency, and backend scaling rather than lab-side expansion. Pain-point tracking shows active work on proposal development and quality control, tying to their stated challenge of hitting 10% revenue growth.
MMS Holdings is a clinical research organization headquartered in Canton, Michigan, supporting pharmaceutical and biotech companies with trial data management, clinical programming, biostatistics, regulatory submissions, and medical writing. The company operates across four continents with a global hiring footprint spanning the United States, United Kingdom, South Africa, and India. MMS maintains a portfolio of active service lines including study programming, statistical analysis (via their KerusCloud platform), and operational strategy support for sponsors. The organization ranges 501–1,000 employees and has operated since 2006.
MMS uses SAS for statistical programming, Veeva RIM for regulatory information management, GraphPad Prism and SAS Prism for graphics, SharePoint for collaboration, Workday for HR, and Microsoft Office suite (Word, Excel, PowerPoint, Outlook) for reporting and communication.
MMS maintains a global footprint and is actively hiring across the United Kingdom, United States, South Africa, and India, supporting their four-continent operational presence.
Other companies in the same industry, closest in size